1. Home
  2. CTKB vs CADL Comparison

CTKB vs CADL Comparison

Compare CTKB & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.16

Market Cap

595.2M

Sector

Health Care

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.88

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
CADL
Founded
1990
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
595.2M
551.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CTKB
CADL
Price
$4.16
$8.88
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$5.63
$19.00
AVG Volume (30 Days)
596.0K
2.0M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$193,015,000.00
$125,000.00
Revenue This Year
$5.42
N/A
Revenue Next Year
$7.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.67
N/A
52 Week Low
$2.37
$4.35
52 Week High
$6.18
$8.36

Technical Indicators

Market Signals
Indicator
CTKB
CADL
Relative Strength Index (RSI) 38.31 79.46
Support Level $4.00 $4.80
Resistance Level $4.26 N/A
Average True Range (ATR) 0.27 0.54
MACD -0.02 0.19
Stochastic Oscillator 8.43 87.59

Price Performance

Historical Comparison
CTKB
CADL

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: